Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
JAMA Oncology
Published October 29, 2026
Doing More With Less in Financially Constrained Health Systems.
October 30, 2026
Medspoke
Medspoke
JAMA Oncology
Published October 29, 2026
00:00
--:--
Benmelstobart With or Without Anlotinib After Chemoradiotherapy for Unresectable Non-Small Cell L...
October 30, 2026
Share
Benmelstobart With or Without Anlotinib After Chemoradiotherapy for Unresectable Non-Small Cell Lung Cancer: The R-ALPS Randomized Clinical Trial.
https://www.medspoke.co/channel_journal?id=686&tap_id=16705
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
JAMA Oncology
Published October 29, 2026
Global, Regional, and National Burden of Bone Cancers, 1990 to 2023, With Forecasts to 2050: A Sy...
October 30, 2026
Why are you reporting this TALK?